tradingkey.logo

Omada Health Inc

OMDA
20.810USD
+0.160+0.77%
Close 11/11, 16:00ETQuotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM

Omada Health Inc

20.810
+0.160+0.77%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Omada Health Inc

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Omada Health Inc's Score

Industry at a Glance

Industry Ranking
70 / 485
Overall Ranking
147 / 4608
Industry
Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 9 analysts
Buy
Current Rating
29.222
Target Price
+41.51%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Omada Health Inc Highlights

StrengthsRisks
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 90.39% year-on-year.
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 42.92M shares, increasing 48.78% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 482.79K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-11

The company's current financial score is 8.37, which is higher than the Software & IT Services industry's average of 7.26. Its financial status is robust, and its operating efficiency is average.

Score

Industry at a Glance

Previous score
8.37
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

6.53

Operational Efficiency

7.73

Growth Potential

10.00

Shareholder Returns

7.61

Omada Health Inc's Company Valuation

Currency: USD Updated: 2025-11-11

The company’s current valuation score is 7.35, which is higher than the Software & IT Services industry's average of 7.30.

Score

Industry at a Glance

Previous score
7.35
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 70/485
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-11

The company’s current earnings forecast score is 7.78, which is higher than the Software & IT Services industry's average of 7.59. The average price target for Omada Health Inc is 29.00, with a high of 33.00 and a low of 24.00.

Score

Industry at a Glance

Previous score
7.78
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 9 analysts
Buy
Current Rating
29.222
Target Price
+41.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

64
Total
7
Median
9
Average
Company name
Ratings
Analysts
Omada Health Inc
OMDA
9
CVS Health Corp
CVS
30
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
26
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-11

The company’s current price momentum score is 6.86, which is lower than the Software & IT Services industry's average of 6.96. Sideways: Currently, the stock price is trading between the resistance level at 25.48 and the support level at 17.57, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.82
Change
0.04

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-1.332
Neutral
RSI(14)
34.622
Neutral
STOCH(KDJ)(9,3,3)
21.801
Neutral
ATR(14)
1.649
High Vlolatility
CCI(14)
-124.587
Sell
Williams %R
77.132
Sell
TRIX(12,20)
-0.161
Sell
StochRSI(14)
29.124
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
21.388
Sell
MA10
23.200
Sell
MA20
24.361
Sell
MA50
23.585
Sell
MA100
21.306
Sell
MA200
20.995
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-11

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Fidelity Management & Research Company LLC
5.59M
--
Revelation Partners, LLC
5.21M
--
U.S. Venture Partners
4.72M
--
Andreessen Horowitz
4.61M
--
Cigna Ventures LLC
3.44M
--
aMoon Fund
2.70M
--
Norwest Venture Partners
2.53M
--
Perceptive Advisors LLC
2.43M
--
Duffy (Sean P M.D.)
2.01M
-0.22%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-11

The company’s current risk assessment score is 5.70, which is higher than the Software & IT Services industry's average of 4.86. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.70
Change
0
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
--
240-Day Volatility
--

Return

Best Daily Return
60 days
--
120 days
--
5 years
--
Worst Daily Return
60 days
--
120 days
--
5 years
--
Sharpe Ratio
60 days
--
120 days
--
5 years
--

Risk Assessment

Maximum Drawdown
240 days
--
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
--
3 years
--
5 years
--
Skewness
240 days
--
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
--
5 years
--
Standardised True Range
240 days
--
5 years
--
Downside Risk-Adjusted Return
120 days
--
240 days
--
Maximum Daily Upside Volatility
60 days
--
Maximum Daily Downside Volatility
60 days
--

Liquidity

Average Turnover Rate
60 days
--
120 days
--
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--

Peer Comparison

Software & IT Services
Omada Health Inc
Omada Health Inc
OMDA
7.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
QXO Inc
QXO Inc
QXO
8.74 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
Amdocs Ltd
DOX
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Akamai Technologies Inc
Akamai Technologies Inc
AKAM
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ePlus inc
ePlus inc
PLUS
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CACI International Inc
CACI International Inc
CACI
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI